Mylan Laboratories India Opposition, Glatiramer Acetate Injection , (2234/Delnp/2007 (Eq. Pct/Us2005/032395 And Us60/608,843))
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
MSN Laboratories Private Limited opposition, Ledipasvir, (9313/DELNP/2011)
Countries: India Date: 2016
-
Ranbaxy Laboratories opposition, ritonavir (r, RTV) , (PCT/2001/00018/MUM)
Countries: India Date: 2005
-
Ranbaxy Laboratories opposition, valganciclovir (VAL) , (959/MAS/1995 (granted as 207232))
Countries: India Date: 2009
-
Panacea Biotech Ltd. opposition, Pneumococcal Conjugate Vaccine, (8081/DELNP/2007)
Countries: India Date: 2016
-
Indian Pharmaceutical Alliance (IPA) opposition, Enzalutamide, (9668/DELNP/2007 (WO2006/124118))
Countries: India Date: 2016
-
Panacea Biotech Limited opposition, Pneumococcal Conjugate Vaccine, (10072/DELNP/2012)
Countries: India Date: 2016
-
Médecins Sans Frontières (MSF) opposition, Pneumococcal Conjugate Vaccine, (8081/DELNP/2007)
Countries: India Date: 2016
-
Panacea Biotech Limited opposition, Pneumococcal Conjugate Vaccine, (10072/DELNP/2012)
Countries: India Date: 2016
-
Panacea Biotech Ltd. opposition, Pneumococcal Conjugate Vaccine, (2533/KOLNP/2008)
Countries: India Date: 2016
-
Natco Pharma Ltd opposition, Sacubitril / Valsartan, (4412/DELNP/2007)
Countries: India Date: 2016